Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ankyrin repeat domain 30B-like pseudogene is a processed or unprocessed pseudogene that shares sequence similarity (homology) with the functional ankyrin repeat domain protein-coding genes, such as ANKRD30B and ANKRD30A. It does not encode a functional protein, as is typical for pseudogenes, though low-level transcription can sometimes occur. While ankyrin repeat proteins typically mediate protein-protein interactions and play roles in signaling, the pseudogene form lacks this function. Preliminary transcriptomic data suggest possible enrichment in inflammatory or cancer-associated tissues, but there is no evidence for a direct regulatory or protein function. Pseudogenes, including this one, are not therapeutic targets and have no established drug interactions or roles as biomarkers[1][2][5][8][10][12][13][14][16].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat domain 30B-like pseudogene.